HARBOURVEST PARTNERS LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 1 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$172,704
-59.6%
986,8780.0%0.06%
-58.6%
Q3 2022$428,000
-49.0%
986,8780.0%0.14%
-49.3%
Q2 2022$840,000
-84.6%
986,8780.0%0.28%
-75.1%
Q1 2022$5,438,000
-43.1%
986,8780.0%1.11%
-9.1%
Q4 2021$9,553,000
-45.9%
986,8780.0%1.22%
-26.3%
Q3 2021$17,645,000
-26.8%
986,8780.0%1.66%
-28.1%
Q2 2021$24,090,000
-7.9%
986,8780.0%2.30%
-34.3%
Q1 2021$26,152,000
+249.2%
986,8780.0%3.51%
+19.8%
Q4 2020$7,490,000
+51.5%
986,8780.0%2.93%
+59.9%
Q3 2020$4,944,000
-16.2%
986,8780.0%1.83%
-28.1%
Q2 2020$5,902,000
+34.4%
986,8780.0%2.54%
+20.0%
Q1 2020$4,392,000
-53.2%
986,8780.0%2.12%
-45.1%
Q4 2019$9,375,000
+21.0%
986,8780.0%3.86%
+19.9%
Q3 2019$7,747,000
-75.0%
986,878
-50.0%
3.22%
-44.5%
Q2 2019$31,048,000
+73.8%
1,973,756
+100.0%
5.81%
-8.1%
Q1 2019$17,862,000
+12.6%
986,8780.0%6.32%
-15.9%
Q4 2018$15,869,000
-33.0%
986,8780.0%7.52%
-64.9%
Q3 2018$23,685,000986,87821.42%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders